Walvax沃森生物
About Us
Our Company
Our Journey
Contact Us
Value of Vaccines
Products
Products List
Production
Distribution
R＆D
R&D Platform
Pipeline
Investors
Media
Collaborations
Career
Responsibility
About Us
Our Company
Our Journey
Contact Us
Value of Vaccines
Products
Products List
Production
Distribution
R＆D
R&D Platform
Pipeline
Investors
Media
Collaborations
Career
Responsibility
CN
EN
Investors
Home
Investors
00
-0.22 (-0.6%)
Stock Code: 300142
Key Facts
2.9 billion
USD2.9 billion market capitalization
344 million
USD344 million revenue in 2025
73 million
USD73 million international business revenue in 2025
25.3 million
USD25.3 million of net profit attributable to Company owners in 2025
1,717 million
USD1,717 million of total asset in 2025
38%
5-year CAGR for international business
Financial Reports
2026.03.28
2025 Annual Report
Download
2025.10.29
2025 Third-Quarter Report
Download
2025.08.26
2025 Interim Report
Download
2025.04.26
2025 First-Quarter Report
Download
2025.04.12
2024 Annual Report
Download
2024.10.26
2024 Third-Quarter Report
Download
2024.08.28
2024 Interim Report
Download
2024.04.25
2024 First-Quarter Report
Download
2024.04.01
2023 Annual Report
Download
2023.10.31
2023 Third-Quarter Report
Download